• Kala Pharmaceuticals Secures Convertible Loan Amid Challenges TipRanks Mon, 10 Nov 2025 13:35:48 GMT
• rules not followed, kala amb drug firm ordered to stop manufacturing Tribune India Wed, 05 Nov 2025 21:30:16 GMT
• partner in kala amb-based pharma firm arrested by ncb The Indian Express Tue, 04 Nov 2025 08:00:00 GMT
• Kala Pharmaceuticals Faces Foreclosure and Leadership Changes TipRanks Mon, 20 Oct 2025 07:00:00 GMT
• kala pharmaceuticals reports mixed late-stage study data for kpi-121 in dry eye disease; shares drop FirstWord Pharma Fri, 03 Oct 2025 04:36:54 GMT
• Kala Pharmaceuticals Faces Default Notice from Oxford Finance TipRanks Wed, 01 Oct 2025 07:00:00 GMT
• kala bio faces diminishing options after eye drug failure insights.citeline.com Tue, 30 Sep 2025 14:18:47 GMT
• Kala Bio scraps development of eye disease drug after trial failure ET Pharma Tue, 30 Sep 2025 07:00:00 GMT
• kala bio halts eye drug development after phase 2b trial failure Medical Dialogues Tue, 30 Sep 2025 07:00:00 GMT
• u.s. shares higher at close of trade; dow jones industrial average up 0.15% Investing.com UK Mon, 29 Sep 2025 21:25:44 GMT
• united states shares higher at close of trade; dow jones industrial average up 0.15% Investing.com India Mon, 29 Sep 2025 20:43:16 GMT
• u.s. stocks higher at close of trade; dow jones industrial average up 0.15% Investing.com Mon, 29 Sep 2025 20:30:00 GMT
• enanta pharmaceuticals stock rises 58% – here’s an important update Stocktwits Mon, 29 Sep 2025 17:51:00 GMT
• Kala Bio Stock Just Plunged 89% Today – Here’s What Happened Stocktwits Mon, 29 Sep 2025 14:03:45 GMT
• kala to cease development of kpi-012, evaluate strategic options TipRanks Mon, 29 Sep 2025 13:56:13 GMT
• Kala Bio stock plunges after failed Phase 2b trial for eye treatment Investing.com Mon, 29 Sep 2025 07:00:00 GMT
• KALA Stock Falls Sharply After KPI-012 Clinical Trial Disappointment GuruFocus Mon, 29 Sep 2025 07:00:00 GMT
• KALA BIO plunges 92% after phase 2 failure of eye condition drug Seeking Alpha Mon, 29 Sep 2025 07:00:00 GMT
• Kala Pharmaceuticals Halts KPI-012 Development After Trial Failure TipRanks Mon, 29 Sep 2025 07:00:00 GMT
• arlington biotech slashes workforce in half after trial failure The Business Journals Mon, 29 Sep 2025 07:00:00 GMT
• big moves in pharma: leadership shuffles and billion-dollar deals Devdiscourse Mon, 29 Sep 2025 07:00:00 GMT
• kala pharmaceuticals downgraded to market perform at lifesci capital TipRanks Mon, 29 Sep 2025 07:00:00 GMT
• kala pharmaceuticals halts kpi-012 development after trial failure TipRanks Sun, 28 Sep 2025 07:00:00 GMT
• strategic positioning and trial design propel kala pharmaceuticals to ‘buy’ rating TipRanks Thu, 18 Sep 2025 07:00:00 GMT
• kala pharmaceuticals price target raised to $35 from $12 at h.c. wainwright TipRanks Wed, 17 Sep 2025 07:00:00 GMT
• analysts offer insights on healthcare companies: kala pharmaceuticals (kala) and milestone pharmaceuticals (mist) The Globe and Mail Tue, 16 Sep 2025 09:50:00 GMT
• kala pharmaceuticals price target raised to $33 from $15 at oppenheimer TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• persistent corneal epithelial defects pipeline analysis, 2025 | pceds clinical trials | eyevance, amber ophthalmics, kala pharmace... The Globe and Mail Mon, 08 Sep 2025 07:00:00 GMT
• kala pharmaceuticals initiated with an outperform at mizuho TipRanks Mon, 08 Sep 2025 07:00:00 GMT
• individual investors are kala bio, inc.'s (nasdaq:kala) biggest owners and were rewarded after market cap rose by us$28m last week... simplywall.st Fri, 05 Sep 2025 07:00:00 GMT
• rare eye disease biotech kala bio to present latest developments at h.c. wainwright conference Stock Titan Wed, 03 Sep 2025 07:00:00 GMT
• kala bio appoints todd bazemore as president, chief executive officer and director Stock Titan Tue, 02 Sep 2025 12:00:00 GMT
• Rare Disease Expert Todd Bazemore Takes Helm at KALA BIO Ahead of Crucial Phase 2b Trial Results Stock Titan Tue, 02 Sep 2025 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Thu, 14 Aug 2025 07:00:00 GMT
• optimistic buy rating for kala pharmaceuticals driven by kpi-012 trial prospects and financial viability TipRanks Wed, 13 Aug 2025 07:00:00 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Mon, 11 Aug 2025 01:12:03 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Sun, 10 Aug 2025 07:00:00 GMT
• suresh kashyap raised issue of paonta kala amb railway line which will benefit pharma industry himachalheadlines.com Thu, 31 Jul 2025 07:00:00 GMT
• shimla mp suresh kashyap seeks rail line to connect pharma hub in paonta sahib and kala amb Times of India Wed, 30 Jul 2025 07:00:00 GMT
• acute ocular pain treatment market forecast to surge by 2034 as key pharma players drive therapeutic innovation delveinsight Menafn Tue, 29 Jul 2025 11:12:27 GMT
• blepharitis drugs market hits new high | major giants allergan (abbvie), novartis, bausch health newstrail.com Sat, 26 Jul 2025 15:57:34 GMT
• cdsco flags 55 substandard, 4 spurious drugs in june batch alert, full list inside Medical Dialogues Sat, 19 Jul 2025 07:00:00 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Sat, 12 Jul 2025 20:05:34 GMT
• kala pharmaceuticals (kala) receives buy rating from ladenburg | kala stock news GuruFocus Fri, 11 Jul 2025 11:01:22 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Fri, 11 Jul 2025 07:50:43 GMT
• FDA publishes drug rejection letters for 15 Massachusetts biotechs The Business Journals Thu, 10 Jul 2025 07:00:00 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Thu, 10 Jul 2025 07:00:00 GMT
• kala bio eyes 100,000 patient market as pivotal pced trial completes enrollment, q3 results ahead Stock Titan Wed, 09 Jul 2025 07:00:00 GMT
• kala pharmaceuticals completes enrollment for phase 2b trial TipRanks Wed, 09 Jul 2025 07:00:00 GMT
• kala completes patient enrollment for chase phase 2 clinical trial TipRanks Wed, 09 Jul 2025 07:00:00 GMT
• top eye disease experts gather to reveal breakthrough pced treatment potential at kala bio kol event Stock Titan Mon, 07 Jul 2025 07:00:00 GMT
• moderate to severe acute pain market report 2034: epidemiology openPR.com Tue, 24 Jun 2025 19:52:00 GMT
• persistent epithelial defects clinical trials, companies, therapeutic assessment, emerging therapies, treatment algorithm, and pip... MenaFN Mon, 23 Jun 2025 11:10:18 GMT
• limbal stem cells deficiency market to expand significantly by 2034, states delveinsight report kala pharma, clips bnc co., rheace... MENAFN.com Tue, 10 Jun 2025 07:06:29 GMT
• palantir vs. snowflake: which ai stock could soar in 5 years? The Globe and Mail Fri, 06 Jun 2025 13:29:00 GMT
• kala pharmaceuticals assumed with an outperform at oppenheimer TipRanks Tue, 03 Jun 2025 04:46:15 GMT
• kala stock gains momentum with oppenheimer's positive outlook | kala stock news GuruFocus Mon, 02 Jun 2025 07:00:00 GMT
• kala pharmaceuticals assumed with an outperform at oppenheimer TipRanks Mon, 02 Jun 2025 07:00:00 GMT
• kala bio to present at jefferies global healthcare conference GlobeNewswire Thu, 29 May 2025 07:00:00 GMT
• alcon gains first fda prescription drug nod since novartis split, scoring with drops for dry eye disease Fierce Pharma Thu, 29 May 2025 07:00:00 GMT
• kala bio to reveal latest eye disease pipeline progress at major jefferies healthcare conference Stock Titan Thu, 29 May 2025 07:00:00 GMT
• kala bio stock target cut to $12 by h.c. wainwright, retains buy Investing.com Sat, 24 May 2025 07:00:00 GMT
• kala pharmaceuticals price target lowered to $12 from $15 at h.c. wainwright TipRanks Fri, 23 May 2025 11:36:29 GMT
• kala price target reduced by h.c. wainwright after q3 results | kala stock news GuruFocus Fri, 23 May 2025 07:00:00 GMT
• best healthcare stocks: eli lilly vs. novo nordisk The Globe and Mail Wed, 21 May 2025 07:00:00 GMT
• kala focuses on advancing kpi-012 development amid pivotal trials | kala stock news GuruFocus Wed, 14 May 2025 13:31:19 GMT
• kala pharmaceuticals reports q1 eps ($1.41) vs ($4.20) last year TipRanks Wed, 14 May 2025 12:41:16 GMT
• kala's pced drug could reach 100,000 patients - q3 trial results coming Stock Titan Wed, 14 May 2025 12:00:00 GMT
• kala bio reports first quarter 2025 financial results and provides corporate update GlobeNewswire Wed, 14 May 2025 07:00:00 GMT
• biodurable ophthalmic drug delivery system market is set to experience a revolutionary growth openPR.com Fri, 09 May 2025 07:00:00 GMT
• blepharitis treatment market 2034: ema, pdma, fda approval, clinical trials, medication, prevalence, nice approval, revenue, stati... Barchart.com Mon, 28 Apr 2025 11:00:00 GMT
• government & technical consulting stocks q4 earnings: ul solutions (nyse:uls) best of the bunch The Globe and Mail Mon, 28 Apr 2025 07:00:00 GMT
• how the (kala) price action is used to our advantage news.stocktradersdaily.com Mon, 21 Apr 2025 08:28:00 GMT
• bombardier inc stock analysis: what to know before q1 2025 results The Globe and Mail Tue, 15 Apr 2025 07:00:00 GMT
• oppenheimer maintains kala bio stock outperform with $15 target by investing.com Investing.com India Mon, 14 Apr 2025 07:00:00 GMT
• kala stock touches 52-week low at $3.4 amid market challenges Investing.com India Sat, 12 Apr 2025 00:13:53 GMT
• kala pharmaceuticals announces executive retention agreements TipRanks Fri, 11 Apr 2025 07:00:00 GMT
• kala stock touches 52-week low at $3.4 amid market challenges Investing.com UK Fri, 11 Apr 2025 07:00:00 GMT
• samuel crossan of jll to speak at boston life sciences conference Boston Real Estate Times Thu, 10 Apr 2025 07:00:00 GMT
• kala pharmaceuticals announces executive retention agreements TipRanks Thu, 10 Apr 2025 07:00:00 GMT
• kala pharmaceuticals: promising clinical developments and financial stability support buy rating TipRanks Fri, 04 Apr 2025 11:03:32 GMT
• h.c. wainwright maintains buy on kala bio, target at $15 Investing.com Fri, 04 Apr 2025 07:00:00 GMT
• oppenheimer maintains outperform on kala pharmaceuticals stock Investing.com Tue, 01 Apr 2025 07:00:00 GMT
• kala pharmaceuticals reports q4 eps ($1.74) vs. ($3.18) last year TipRanks Tue, 01 Apr 2025 01:57:45 GMT
• kala bio reports fourth quarter and full year 2024 financial results and provides corporate update GlobeNewswire Mon, 31 Mar 2025 07:00:00 GMT
• kala bio secures 2-year cash runway as phase 2b trial hits 87 patient milestone Stock Titan Mon, 31 Mar 2025 07:00:00 GMT
• drug alert: 47 drug samples fail to clear cdsco test, 1 declared spurious Medical Dialogues Mon, 31 Mar 2025 07:00:00 GMT
• (kala) pivots trading plans and risk controls news.stocktradersdaily.com Sat, 15 Mar 2025 05:38:00 GMT
• cyclosporine 0.09% improved dry eye signs in patients previously treated with 0.05% Healio Tue, 11 Mar 2025 07:00:00 GMT
• kala bio to present at td cowen 45th annual health care conference StockTitan Wed, 26 Feb 2025 13:00:00 GMT
• what will kala bio reveal at the td cowen healthcare conference next week? Stock Titan Wed, 26 Feb 2025 08:00:00 GMT
• trading (kala) with integrated risk controls news.stocktradersdaily.com Fri, 21 Feb 2025 08:00:00 GMT
• india develops new drug to tackle burden of kala-azar, antibiotic to fight amr OTV News Fri, 21 Feb 2025 08:00:00 GMT
• acute ocular pain drugs market 2034: ema, pdma, fda approvals, openPR Tue, 18 Feb 2025 08:00:00 GMT
• david schenkein resigns from agios’ board; moderna hires roivant exec as chief marketing officer Endpoints News Fri, 14 Feb 2025 08:00:00 GMT
• amd is a top artificial intelligence (ai) stock to buy after its recent earnings The Globe and Mail Fri, 14 Feb 2025 08:00:00 GMT
• kala bio appoints new interim ceo amid leadership shuffle by investing.com Investing.com Canada Thu, 13 Feb 2025 00:18:13 GMT
• kala bio, inc. announces chief executive officer changes -february 12, 2025 at 08:00 am est Marketscreener.com Wed, 12 Feb 2025 14:56:38 GMT
• leadership shake-up at kala bio: new ceo takes helm before crucial phase 2b eye treatment results Stock Titan Wed, 12 Feb 2025 08:00:00 GMT
• kala bio appoints new interim ceo amid leadership shuffle Investing.com Wed, 12 Feb 2025 08:00:00 GMT
• kala bio announces ceo departure, appoints interim leader Investing.com Wed, 12 Feb 2025 08:00:00 GMT
• kala bio chief executive mark iwicki resigns; shares fall -february 12, 2025 at 11:59 am est Marketscreener.com Wed, 12 Feb 2025 08:00:00 GMT
• dollar gains and gold rallies to a record high on us tariffs The Globe and Mail Mon, 10 Feb 2025 08:00:00 GMT
Kala Pharmaceuticals, Inc(NASDAQ:KALA) 
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS...
Website: http://www.kalarx.com
Founded: 2009
Full Time Employees: 136
Sector: Healthcare
Industry: Biotechnology